Research programme: adenosine A2A receptor antagonists - Kyowa Kirin
Alternative Names: K-056Latest Information Update: 16 Jul 2019
At a glance
- Originator Kyowa Hakko; Kyowa Hakko Kirin - Mitsui Knowledge (JV)
- Developer Kyowa Hakko Kirin
- Class Antidepressants; Antiparkinsonians; Sleep disorder therapies
- Mechanism of Action Adenosine A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Migraine; Parkinson's disease; Sleep disorders
Most Recent Events
- 28 Oct 2016 Discontinued - Preclinical for Migraine in Japan (unspecified route)
- 28 Oct 2016 Discontinued - Preclinical for Parkinson's disease in Japan (unspecified route)
- 28 Oct 2016 Discontinued - Preclinical for Sleep disorders in Japan (unspecified route)